ORIENT BIO Company Description

ORIENT BIO Inc. operates in the bio-industry in South Korea and internationally.

It engages in the production, export, import, and life science-related research and development of laboratory animals; and offers various equipment for research environment.

The company also provides infrastructural solution; health checking; generic testing; molecular biological generic testing; generic transformation; phenotyping; preconditioning; surgical treatment; transgenic services; eggs and avian research; support services for husbandry tasks; diagnostic and kits; claim management; serology regents; supply of biological materials used for new drug development process; and mouse, rat, and hamster antibody production testing services.

In addition, it engages in automotive and automobile parts production and sales; preclinical and clinical trial agency business; manufacturing, import, and export pharmaceuticals, manufacturing, processing, wholesaling, and retailing of watches; and construction works.

It has strategic partnerships with ELLEGARD in the Netherlands and CSIMC in China. It serves research institutions, pharmaceutical companies, and healthcare providers.

The company was formerly known as Orient Co., Ltd. and changed its name to ORIENT BIO Inc. in 2005.

ORIENT BIO Inc. was founded in 1959 and is headquartered in Seongnam-si, South Korea.

ORIENT BIO Inc.

Country	South Korea
Founded	1959
Industry	Biotechnology
Sector	Healthcare
Employees	125
CEO	Jae-Jin Chang

Contact Details

Address: 322, Galmachi-ro Seongnam-si South Korea
Phone	82 31 730 6000
Website	orient.co.kr

Stock Details

Ticker Symbol	002630
Exchange	Korea Stock Exchange
Stock Type	Common Stock
Fiscal Year	April - March
Reporting Currency	KRW
ISIN Number	KR7002630002
SIC Code	8734

Key Executives

Name	Position
Jae-Jin Chang	Chairperson, President and Chief Executive Officer
Tae-Seok Han	Managing Director of Sales